KOGENATE BAYER
250IU INJ PSO LQF 1+1X2,5ML ISP II
| SÚKL code | 0027196 |
|---|---|
| Name of the product | KOGENATE BAYER |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | KOGENATE BAYER |
| Supplement | 250IU INJ PSO LQF 1+1X2,5ML ISP II |
| Strenght | 250IU |
| Pharmaceutical form | Powder and solvent for solution for injection |
| Package | 1+1X2,5ML ISP II |
| Route | Intravenous use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance | OCTOCOG ALFA (OCTOCOGUM ALFA) |
| ATC group | B02BD02 |
| ATC group name | KOAGULAČNÍ FAKTOR VIII |
Marketing authorisation information
| Registration Number | EU/1/00/143/007 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Bayer AG, Leverkusen |
| MA Holder country | NĚMECKO |
cz